KBC Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94K | Sell |
685
-254
| -27% | -$34.9K | ﹤0.01% | 1235 |
|
|
2025
Q1 | $169K | Hold |
939
| – | – | ﹤0.01% | 1165 |
|
|
2024
Q4 | $147K | Buy |
939
+297
| +46% | +$46.5K | ﹤0.01% | 1312 |
|
|
2024
Q3 | $117K | Buy |
642
+132
| +26% | +$24.1K | ﹤0.01% | 1186 |
|
|
2024
Q2 | $94K | Buy |
510
+37
| +8% | +$6.82K | ﹤0.01% | 1212 |
|
|
2024
Q1 | $84K | Hold |
473
| – | – | ﹤0.01% | 1222 |
|
|
2023
Q4 | $59K | Hold |
473
| – | – | ﹤0.01% | 1398 |
|
|
2023
Q3 | $55K | Buy |
+473
| New | +$55K | ﹤0.01% | 1376 |
|
|
2021
Q4 | – | Sell |
-1,975
| Closed | -$103K | – | 1316 |
|
|
2021
Q3 | $103K | Sell |
1,975
-1,975
| -50% | -$103K | ﹤0.01% | 1159 |
|
|
2021
Q2 | $268K | Hold |
3,950
| – | – | ﹤0.01% | 1136 |
|
|
2021
Q1 | $304K | Hold |
3,950
| – | – | ﹤0.01% | 1130 |
|
|
2020
Q4 | $1.3M | Hold |
3,950
| – | – | ﹤0.01% | 1104 |
|
|
2020
Q3 | $170K | Hold |
3,950
| – | – | ﹤0.01% | 1136 |
|
|
2020
Q2 | $164K | Buy |
3,950
+3,575
| +953% | +$148K | ﹤0.01% | 1174 |
|
|
2020
Q1 | $16K | Hold |
375
| – | – | ﹤0.01% | 1262 |
|
|
2019
Q4 | $21K | Sell |
375
-5,390
| -93% | -$302K | ﹤0.01% | 1452 |
|
|
2019
Q3 | $200K | Buy |
5,765
+2,490
| +76% | +$86.4K | ﹤0.01% | 1251 |
|
|
2019
Q2 | $132K | Hold |
3,275
| – | – | ﹤0.01% | 1286 |
|
|
2019
Q1 | $108K | Buy |
3,275
+350
| +12% | +$11.5K | ﹤0.01% | 1270 |
|
|
2018
Q4 | $61K | Buy |
2,925
+700
| +31% | +$14.6K | ﹤0.01% | 1200 |
|
|
2018
Q3 | $39K | Hold |
2,225
| – | – | ﹤0.01% | 1342 |
|
|
2018
Q2 | $33K | Hold |
2,225
| – | – | ﹤0.01% | 1248 |
|
|
2018
Q1 | $22K | Buy |
2,225
+1,225
| +123% | +$12.1K | ﹤0.01% | 1248 |
|
|
2017
Q4 | $11K | Buy |
+1,000
| New | +$11K | ﹤0.01% | 1245 |
|